BUHPF (BUHPF) Stock Price & Analysis
BUHPF (BUHPF) rose 0.00% to USD 5.45 as of June 10, 2026 at 05:31 UTC, according to Nexqual real-time market data.
BUHPF last closed at USD 5.45; the session ranged USD 5.45–5.45 on volume of 100 shares. Market capitalization is $4.38B, with a 52-week range of USD 4.85–5.65 (PNK). Source: Nexqual, June 10, 2026 at 05:31 UTC.
Key Statistics (as of June 10, 2026 at 05:31 UTC)
| Price | USD 5.45 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 5.45 |
| Open | USD 5.45 |
| Day Range | USD 5.45 – 5.45 |
| 52-Week Range | USD 4.85 – 5.65 |
| Volume | 100 shares |
| Market Cap | $4.38B |
| Exchange | PNK |
Technical Analysis (BUHPF)
Nexqual's technical model rates BUHPF "STRONG SELL" based on 1 bullish and 6 bearish signals across 123 daily candles, as of June 10, 2026 at 05:31 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 5.5) |
| MACD | -0.01 (negative) |
Analyst Ratings (BUHPF)
Wall Street analysts rate BUHPF "None", per Nexqual as of June 10, 2026 at 05:31 UTC.
| Consensus Rating | None |
|---|
Earnings (BUHPF)
| Revenue Estimate | $6.13B |
|---|
Source: Nexqual, June 10, 2026 at 05:31 UTC.
Financials & Fundamentals (BUHPF)
| Total Revenue | $25.49B |
|---|---|
| Revenue Growth (YoY) | +0.70% |
| Gross Margin | +52.40% |
| Operating Margin | +34.70% |
| Profit Margin | +29.69% |
| ROE | +24.38% |
| Debt / Equity | 0.31 |
| Current Ratio | 4.48 |
| Total Cash | $14.34B |
| Total Debt | $103.64M |
| Free Cash Flow | $3.18B |
Source: Nexqual, June 10, 2026 at 05:31 UTC.
Financial Health Score (BUHPF)
Nexqual rates BUHPF's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 05:31 UTC.
| Growth | Weak — Revenue -2% YoY (annual), declining |
|---|---|
| Profitability | Strong — Gross margin 52%, operating 35% |
| Balance Sheet | Strong — $14.3B cash vs $104M debt, net cash position |
| Cash Flow | Solid — FCF $3.18B, 13% margin |
| Efficiency | Strong — ROE 24%, ROA 15.7% |
Ownership (BUHPF)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +9.98% |
| Shares Outstanding | 0 |
| Float | 713.11M |
Source: Nexqual, June 10, 2026 at 05:31 UTC.
Leadership (BUHPF)
BUHPF is led by Artirat Charukitpipat (age 57), Chief Executive Officer, per Nexqual as of June 10, 2026 at 05:31 UTC.
| Chief Executive Officer | Artirat Charukitpipat (age 57) |
|---|---|
| President, MD & Executive Director | Linda Lisahapanya (age 72) |
| Chief Financial Officer | Oraphan Buamuang (age 51) |
| Corporate Chief Strategy Officer | Aniello M. Sorrentino (age 77) |
Major Backers & Investors (BUHPF)
Notable institutional backers of BUHPF include MFS SERIES TRUST X-MFS Emerging Markets Equity Fund, DFA INVESTMENT DIMENSIONS GROUP INC-Emerging Markets Core Eqy. 2 PORT., according to Nexqual as of June 10, 2026 at 05:31 UTC.
Active Investors
| Investor | Stake |
|---|---|
| MFS SERIES TRUST X-MFS Emerging Markets Equity Fund | 0.63% |
| DFA INVESTMENT DIMENSIONS GROUP INC-Emerging Markets Core Eqy. 2 PORT. | 0.24% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.27% |
Source: Nexqual, June 10, 2026 at 05:31 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CLCGY | Clicks Group Ltd | USD 28.49 | ▲ 0.35% |
| SHTDF | SINOPHARM GROUP CO. LTD. | USD 2.3 | ▲ 0.44% |
| WILLF | Demant AS | USD 38.78 | ▲ 9.39% |
| SHPMY | Shanghai Pharmaceuticals Holdin | USD 7.6 | ▲ 0% |
| SKHCF | Sonic Healthcare Ltd. | USD 14.58 | ▲ 21.5% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:31 UTC. This page is informational and not investment advice.